Bristol-Myers And BioNTech Deal: Good For Both; One Is Better Investment (BMY) (BNTX)

Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I like BMY more than BNTX.